Targeting neuroendocrine abnormalities in Parkinson’s disease with exercise

Keyphrases

• Parkinson's Disease 100%
• Aging 20%
• Clinical Trials 20%
• Homeostasis 20%
• Disease Progression 20%
• Melatonin 20%
• Circadian Rhythm Disorders 20%
• Resilience 20%
• Neuroprotective 20%
• Vitamin D 20%
• Insulin 20%
• Mechanistic Pathway 20%
• Age-related 20%
• Neurodegenerative Conditions 20%
• Disease-modifying Therapy 20%
• Symptomatology 20%
• Klotho 20%
• Exercise Effect 20%
• Positive Outcomes 20%
• Cortisol 20%
• Non-motor Symptoms of Parkinson's Disease 20%
• Multiple Systems 20%
• Pathophysiological Processes 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Parkinson's Disease 100%
• Diseases 33%
• Clinical Trial 16%
• Symptomatology 16%
• Biological Marker 16%
• Vitamin D 16%
• Disease Exacerbation 16%
• Physical Disease by Body Function 16%
• Melatonin 16%
• Hydrocortisone 16%
• Circadian Rhythm Sleep Disorder 16%
• Neuroprotective Agent 16%

Neuroscience

• Parkinson's Disease 100%
• Neuroprotective Agent 16%
• Cortisol 16%
• Melatonin 16%
• Neuroendocrine System 16%
• Non-Motor Symptoms 16%
• Vitamin D 16%
• Circadian Rhythm Sleep Disorder 16%